amino-terminal propeptide (PINP) antibody and antigen (Recombinant protein)

Diagnostic amino-terminal propeptide (PINP) antibodies (anti-amino-terminal propeptide, anti-PINP) and antigens (recombinant amino-terminal propeptide (PINP) protein) for Metabolic diseases PINP detection in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.

Target products collectionGo to Neurodegenerative diseases diagnostics products collection >>


Product information

Catalog No. Description US $ Price (per mg)
GMP-h-PINP-Ag01 Recombinant human COL1A1/PINP Protein 3090
GMP-h-PINP-Ab01 Anti-human COL1A1/PINP mouse monoclonal antibody (mAb) 1953
GMP-h-PINP-Ab02 Anti-human COL1A1/PINP mouse monoclonal antibody (mAb) 1953
GMP-h-PINP-Ab03 Anti-human COL1A1/PINP human monoclonal antibody (mAb) 1953
GMP-h-PINP-Ab04 Anti-human COL1A1/PINP human monoclonal antibody (mAb) 1953

Size: 1mg | 10mg | 100mg



Product Description

Cat No. of Products GMP-h-PINP-Ag01
Product Name Recombinant human COL1A1/PINP Protein
Target/Biomarker amino-terminal propeptide (PINP)
Alias of Target/Biomarker CAFYD, EDSARTH1, EDSC, OI1, OI2, OI3, OI4
Expression platform mammalian
Isotypes Recombinant Antigen
Bioactivity validation amino-terminal propeptide (PINP) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in PINP level test of Metabolic diseases (osteoporosis therapy) and related syndrome evaluation.
Tag His
Products description Recombinant human COL1A1/PINP Protein was expressed in mammalian expression system and is expressed with 6 HIS tag at the C-terminus.
Purity Purity: ≥95% (SDS-PAGE)
Application positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products GMP-h-PINP-Ab01, GMP-h-PINP-Ab02
Product Name Anti-human COL1A1/PINP mouse monoclonal antibody (mAb)
Target/Biomarker amino-terminal propeptide (PINP)
Alias of Target/Biomarker CAFYD, EDSARTH1, EDSC, OI1, OI2, OI3, OI4
Expression platform CHO
Isotypes Mouse IgG
Bioactivity validation amino-terminal propeptide (PINP) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in PINP level test of Metabolic diseases (osteoporosis therapy) and related syndrome evaluation.
Tag mFc
Products description Anti-human COL1A1/PINP mouse monoclonal antibody (mAb) was expressed in CHO expression system and is expressed with 6 HIS tag at the C-terminus.
Purity Purity: ≥95% (SDS-PAGE)
Application ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products GMP-h-PINP-Ab03, GMP-h-PINP-Ab04
Product Name Anti-human COL1A1/PINP human monoclonal antibody (mAb)
Target/Biomarker amino-terminal propeptide (PINP)
Alias of Target/Biomarker CAFYD, EDSARTH1, EDSC, OI1, OI2, OI3, OI4
Expression platform CHO
Isotypes Human lgG1
Bioactivity validation amino-terminal propeptide (PINP) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in PINP level test of Metabolic diseases (osteoporosis therapy) and related syndrome evaluation.
Tag hFc
Products description Anti-human COL1A1/PINP human monoclonal antibody (mAb) was expressed in CHO expression system and is expressed with 6 HIS tag at the C-terminus.
Purity Purity: ≥95% (SDS-PAGE)
Application ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Validation Data


    Click to get more Data / Case study about the product.



    Target/Biomarker information

    Procollagen type I propeptides are derived from collagen type I, which is the most common collagen type found in mineralized bone. In bone, collagen is synthesized by osteoblasts in the form of procollagen. This precursor contains a short signal sequence and terminal extension peptides: amino-terminal propeptide (PINP) and carboxy-terminal propeptide. These propeptide extensions are removed by specific proteinases before the collagen molecules form. Both propeptides can be found in the circulation and their concentration reflects the synthesis rate of collagen type I. Although collagen type I propeptides may also arise from other tissues (such as the skin, vessels, fibrocartilage, and tendons), most nonskeletal tissues exhibit a slower turnover than bone, and contribute very little to the circulating pool of PINP. PINP is considered the most sensitive marker of bone formation and it is particularly useful for monitoring bone formation therapies and antiresorptive therapies; it is recommended that the test be performed at baseline before starting osteoporosis therapy and performed again 3 to 6 months later.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.

    Comments


    James Garcia 2023-10-19 16:40:21
    The antigen is quite stable and gives good quality results which is suitable for Lateral Flow Immunoassay (LFIA). It guarantees that the diagnosis outcomes will be accurate and reliable.

    Leave a comment